See the new treatment that will break a Pfizer monopoly on a drug for heart disease.

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Bolivia’s highest court has approved the extradition to the United States of a former anti-narcotics chief on charges of ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...

Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...

Vaping is coming before the Supreme Court next week as federal regulators ask the high court to uphold its block on sweet, ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

The rate of Floridians getting medicinal abortions fell by nearly four percentage points between 2021 and 2022, but ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in ...

Xcopri is being heralded by the Canadian Epilepsy Alliance and the Canadian League Against Epilepsy as a promising treatment for partial onset seizures in adults.